HighVista Strategies’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $825K | Buy |
88,876
+3,635
| +4% | +$33.7K | 0.3% | 114 |
|
|
2025
Q1 | $625K | Hold |
85,241
| – | – | 0.24% | 120 |
|
|
2024
Q4 | $728K | Buy |
85,241
+20,214
| +31% | +$173K | 0.27% | 113 |
|
|
2024
Q3 | $566K | Buy |
65,027
+3,168
| +5% | +$27.6K | 0.2% | 119 |
|
|
2024
Q2 | $423K | Buy |
+61,859
| New | +$423K | 0.15% | 119 |
|
|
2022
Q1 | – | Sell |
-58,965
| Closed | -$411K | – | 93 |
|
|
2021
Q4 | $411K | Sell |
58,965
-10,097
| -15% | -$70.4K | 0.33% | 67 |
|
|
2021
Q3 | $691K | Buy |
69,062
+7,423
| +12% | +$74.3K | 0.46% | 62 |
|
|
2021
Q2 | $875K | Buy |
+61,639
| New | +$875K | 0.62% | 31 |
|